Purpose: This phase II, open-label, multicenter study assessed the efficacy and safety of the potential radiation enhancer RSR13 plus cranial radiation therapy (RT) in patients with brain metastases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback